Medications for High Cholesterol, Familial Homozygous
Other names: Familial Hypercholesterolemia, Homozygous; Homozygous Familial Hypercholesterolemia; Homozygous FH; Hypercholesterolemia, Familial Homozygous
Drugs used to treat High Cholesterol, Familial Homozygous
The following list of medications are in some way related to or used in the treatment of this condition.
Drug name | Rating | Reviews | Activity ? | Rx/OTC | Pregnancy | CSA | Alcohol |
---|---|---|---|---|---|---|---|
atorvastatin | 2.8 | 4 reviews | Rx | ||||
Generic name: atorvastatin systemic Brand name: Lipitor Drug class: statins For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
Crestor | 5.5 | 2 reviews | Rx | ||||
Generic name: rosuvastatin systemic Drug class: statins For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
simvastatin | 1.0 | 1 review | Rx | ||||
Generic name: simvastatin systemic Brand names: Zocor, FloLipid Drug class: statins For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
Repatha | 6.8 | 24 reviews | Rx | ||||
Generic name: evolocumab systemic Drug class: PCSK9 inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Lipitor | 3.3 | 3 reviews | Rx | ||||
Generic name: atorvastatin systemic Drug class: statins For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
rosuvastatin | 4.0 | 3 reviews | Rx | ||||
Generic name: rosuvastatin systemic Brand names: Crestor, Ezallor Drug class: statins For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
evolocumab | 6.8 | 24 reviews | Rx | ||||
Generic name: evolocumab systemic Brand name: Repatha Drug class: PCSK9 inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph |
|||||||
Vytorin | Rate | Add review | Rx | ||||
Generic name: ezetimibe / simvastatin systemic Drug class: antihyperlipidemic combinations For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Zocor | Rate | Add review | Rx | ||||
Generic name: simvastatin systemic Drug class: statins For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Juxtapid | Rate | Add review | Rx | ||||
Generic name: lomitapide systemic Drug class: miscellaneous antihyperlipidemic agents For consumers: dosage, interactions, side effects |
|||||||
ezetimibe / simvastatin | Rate | Add review | Rx | ||||
Generic name: ezetimibe / simvastatin systemic Brand name: Vytorin Drug class: antihyperlipidemic combinations For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
lomitapide | Rate | Add review | Rx | ||||
Generic name: lomitapide systemic Brand name: Juxtapid Drug class: miscellaneous antihyperlipidemic agents For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
Praluent | 5.7 | 3 reviews | Rx | ||||
Generic name: alirocumab systemic Drug class: PCSK9 inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Ezallor | 1.0 | 1 review | Rx | ||||
Generic name: rosuvastatin systemic Drug class: statins For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
FloLipid | Rate | Add review | Rx | ||||
Generic name: simvastatin systemic Drug class: statins For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
alirocumab | 5.7 | 3 reviews | Rx | ||||
Generic name: alirocumab systemic Brand name: Praluent Drug class: PCSK9 inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph |
|||||||
Evkeeza | Rate | Add review | Rx | ||||
Generic name: evinacumab systemic Drug class: miscellaneous antihyperlipidemic agents For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
evinacumab | Rate | Add review | Rx | ||||
Generic name: evinacumab systemic Brand name: Evkeeza Drug class: miscellaneous antihyperlipidemic agents For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph |
|||||||
Roszet | Rate | Add review | Rx | ||||
Generic name: ezetimibe / rosuvastatin systemic Drug class: antihyperlipidemic combinations For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
ezetimibe / rosuvastatin | Rate | Add review | Rx | ||||
Generic name: ezetimibe / rosuvastatin systemic Brand name: Roszet Drug class: antihyperlipidemic combinations For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Learn more about High Cholesterol, Familial Homozygous
- Atorvastatin (Lipitor): Top 12 Drug Facts You Need to Know
- Cholesterol Medications and Alcohol Interactions
- Cholesterol Overview: Know Your Risk
- Your Guide on How to Lower Cholesterol
Symptoms and treatments
Legend
Rating | For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). |
---|---|
Activity | Activity is based on recent site visitor activity relative to other medications in the list. |
Rx | Prescription only. |
OTC | Over-the-counter. |
Rx/OTC | Prescription or Over-the-counter. |
Off-label | This medication may not be approved by the FDA for the treatment of this condition. |
EUA | An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives. |
Pregnancy Category | |
---|---|
A | Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
C | Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
X | Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits. |
N | FDA has not classified the drug. |
Controlled Substances Act (CSA) Schedule | |
---|---|
M | The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication. |
U | CSA Schedule is unknown. |
N | Is not subject to the Controlled Substances Act. |
1 | Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision. |
2 | Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
3 | Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
4 | Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
5 | Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
Alcohol | |
---|---|
X | Interacts with Alcohol. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.